No 10Y consistency score yet for revenue — the window needs more comparable quarters.
Valuation vs own 10Y history: P/S 4.4x · 10Y median 9.4x · 6th percentile · as of Oct 6, 2026
Annualized revenue (TTM) · by quarter, last 23
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Quote observation: 2026-10-06T20:57:10.450Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
The latest delayed quote for Hyperfine, Inc. (HYPR) stock was $0.87 as of Oct 6, 2026, 4:00 PM EDT, down 1.46% from the previous close.
Longer view (total return, dividends reinvested): past 12 months -40.2% · 3-year avg -22.5%/yr · 5-year avg -38.3%/yr
Hyperfine, Inc., a health technology company, engages in the production, supply, service, and commercialization of magnetic resonance imaging (MRI) products. Its Swoop Portable MR Imaging System produces images at a lower magnetic field strength than conventional MRI scanners.
Medical - Devices · Guilford, CT
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
Next Earnings Date
Nov 12, 2026
37 days away
EPS Estimate
-0.08
Revenue Est.
$5.12M
Last Quarter Results
EPS
$-0.09
vs Estimate
$-0.09
Revenue
$3.90M
vs Estimate
$4.13M
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1HYPR | $73.27M | $0.87 | -1.46% | -40.20% | -38.34% | N/A | N/A |
| 2HYFT | $72.83M | $1.55 | +4.03% | -11.78% | -23.93% | N/A | vs HYPR |
| 3VRCA | $72.32M | $4.21 | -2.32% | -7.67% | -48.68% | N/A | vs HYPR |
| 4LUNG | $75.18M | $1.78 | -5.32% | +2.16% | -45.30% | N/A | vs HYPR |
| 5GANX | $71.23M | $1.67 | -1.18% | -11.93% | -25.06% | N/A | vs HYPR |
| 6TLSA | $70.63M | $1.11 | +3.74% | -45.53% | -5.37% | N/A | vs HYPR |
forward FY estimate
N/A
Consensus Rating
Based on 3 analysts
Average Price Target
$2.03
+133.7% upside
Low
$1.60
Current
$0.87
High
$2.50
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $-0.08 | $-0.08 | $-0.08 | 1 |
| Quarter ending Dec 2026 | $-0.08 | $-0.08 | $-0.08 | 1 |
| Quarter ending Mar 2027 | $-0.09 | $-0.09 | $-0.09 | 1 |
| Quarter ending Jun 2027 | $-0.08 | $-0.08 | $-0.08 | 1 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2026 | $-0.34 | $-0.34 | $-0.34 | 2 |
| FY 2027 | $-0.32 | $-0.32 | $-0.32 | 1 |
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $5.09M | $5.12M | $5.17M | 2 |
| Quarter ending Dec 2026 | $7.17M | $7.21M | $7.28M | 2 |
| Quarter ending Mar 2027 | $5.17M | $5.20M | $5.25M | 1 |
| Quarter ending Jun 2027 | $5.46M | $5.50M | $5.55M | 1 |
Annual
| Period | Low |
|---|
Source: FMP Analyst Consensus Estimates. Forward P/E is unavailable for the current price and estimate observations.
| Avg |
|---|
| High |
|---|
| # Analysts |
|---|
| FY 2026 | $20.05M | $20.17M | $20.33M | 2 |
| FY 2027 | $26.00M | $26.25M | $26.50M | 2 |
